AD/PD - Advances in Science & Therapy

And...that’s a wrap for #ADPD2026!✨ What an unforgettable few days in Copenhagen - filled with inspiring science, meaningful connections, and incredible moments shared across the global AD/PD™ community. 🧠🌍 Thank you to everyone who joined us - onsite and online - for being part of this journey. 🇪🇸 We can’t wait to see you next year in Barcelona for AD/PD™ 2027! #Neuroscience #Alzheimers #Parkinsons #NeurodegenerativeDiseases #ADPDCommunity #SeeYouInBarcelona

#ADPD2026: Day 5 Highlights, Reflections, and Excitement from Copenhagen! 🌍✨ In the last recap video, @YentliSA, PhD, an MD-PhD student at the University of Pennsylvania, and @iampriyasuman, Ph.D., a neuroscience candidate at @uOttawa Research Institute, joined us to share highlights from the conference and reflect on their experience in Copenhagen. From inspiring sessions to meaningful discussions, their insights truly capture the essence of this year’s event! 🎥 Watch the full recap to hear their takeaways, personal experiences, and the exciting future of neurodegenerative disease research. ✨ Thank you to everyone who joined us in Copenhagen and online - see you next year! #ResearchInnovation #ScientificCommunity #neuroinflammation

All good things must come to an end, and while the Acumen team is sad to leave #ADPD2026, it’s been a wonderful week of sharing knowledge and innovation in the #Alzheimer’s field. We’ll see you all next year at @adpdnet 2027!

#KenesOriginalEvents✨

Exciting Developments in Alzheimer’s Research at #ADPD2026! 🧠✨ Prof. Catherine Mummery, ImmunoBrain, has presented new data from the first clinical study in Alzheimer’s disease (#AD) patients, evaluating IBC-Ab002, an inhibitory immune checkpoint blockade therapeutic approach. The results show favorable safety, tolerability, and directionally favorable changes in biomarkers, offering a new potential pathway for treating Alzheimer's. This innovative therapy, developed by Professor Michal Schwartz, Tommaso Croese, and their team, could be a game-changer in the fight against neurodegeneration. | @WeizmannScience 🎥Stay tuned for more as we continue exploring these incredible breakthroughs at #ADPD2026! 🔬 #Neuroscience #Alzheimers #Parkinsons #ImmuneTherapy #NeurodegenerativeDiseases #ResearchInnovation

Crowdsourced insight from the #AlzheimersDisease research community: #ADPD2026 attendees see the tau hypothesis as most promising for treatment, followed by amyloid and mitochondrial dysfunction. What do you think we’re still missing? @adpdnet #endalz

That’s a wrap #ADPD2026! In this 20th edition, the #BBRC contributed four oral presentations and two posters, reflecting the centre's broad research lines spanning biomarkers, proteomics, neuroimaging, and women's brain health. 👇 barcelonabeta.org/en/news/news/b…

Closing Ceremony starts in 5 min!🤩 #ADPD2026 Join us at 19:05 in 📍Hall A2 for the official AD/PD™ 2026 Closing Ceremony!

🎥 Jacquelyn Shapiro, @IsraelParaSport, shares her powerful family story and insights from her poster presentation at #ADPD2026. Watch as she highlights the importance of her research in the fight against Alzheimer's and Parkinson’s disease. 🌟 A heartfelt and inspiring session you won’t want to miss! #Alzheimers #Parkinsons #NeurodegenerativeDiseases #ResearchImpact #ADPDSpeakers

🎉 We had an incredible Day 4 at #ADPD2026! 🙌 From impactful plenary lectures to in-depth sessions, today was packed with groundbreaking discussions and inspiring innovations in Alzheimer's and Parkinson’s research! 🧠✨ We kicked off the day with an insightful plenary by Aviv Regev on "From Cell Atlases to Medicines, with AI," exploring the intersection of cutting-edge science and artificial intelligence. 🤖🔬 Throughout the day, we saw fascinating sessions on topics like: ✅ Molecular Neuroinflammation Pathways ✅ Synaptic Dysfunction & Biomarkers in AD/PD …and much more! 💡 We also had Forum 04 discussing the translational R&D for α-Synuclein, LRRK2, and GBA Pathologies, as well as innovative approaches for neurodegeneration. 📸 Stay tuned for more highlights, and enjoy what Day 5 brings! #NeurodegenerativeDiseases #ResearchInnovation #ADPD2026 #Alzheimers #Parkinsons #Neuroinflammation #AI #ScientificBreakthroughs

#ADPD2026: Plenary Lecture 06 🌟 This morning, we had the privilege of attending an insightful plenary session by Malú G. Tansey on "The Role of Peripheral Inflammation in Neurodegenerative Disease: Who Let the Dogs Out?" 🧠✨ Her talk delved into the crucial role that peripheral inflammation plays in the progression of neurodegenerative diseases, offering a new perspective on the mechanisms underlying Alzheimer's, Parkinson’s, and other conditions. It was an inspiring start to the last day of #ADPD2026! 🙌 #Neuroinflammation #NeurodegenerativeDiseases #Alzheimers #Parkinsons #ADPD2026 #Neuroscience #ResearchInnovation #PeripheralInflammation

⏳ Last chance to enter the #ADPD2026 Photo Contest! Don’t miss out on your chance to win free registration for AD/PD™ 2027! Post your best moments from the conference and tag them with #ADPD2026 before Saturday, March 21, 08:00 pm CET. 📸 🤳 🔗 😊 adpd.kenes.com/adpd2026-photo… #PhotoContest #Neuroscience #Alzheimers #Parkinsons #Copenhagen2026

@AlzData’s, @niranjanbose, reminds the group of the origin of the #AI prize, with a video from @BillGates, “thank you to all of you for not accepting this disease as inevitable.” #ADPD2026 @adpdnet

Wait wait what?!?!? There are going to be two first prize winners thanks to another generous donation! Woo hoo!!! @AlzData #AI @niranjanbose #ADPD2026 @adpdnet

Alpha synuclein structure and aggregation in Parkinson’s #ADPD2026 youtube.com/shorts/TRUDLBB… via @YouTube

Endolysosomal targets in Alzheimer’s and Parkinson’s #ADPD2026 youtube.com/shorts/JqD9cOV… via @YouTube

Predicting dementia risk using electronic health records #ADPD2026 youtube.com/shorts/5yKP3MC… via @YouTube

Personality traits and dementia risk across ageing cohorts #ADPD2026 youtube.com/shorts/UXKMiRr… via @YouTube

Poster in a Short 🎥 Megan Hodgson from PSPA shares her #ADPD2026 poster on diagnostic delays in PSP and impact on quality of life. youtube.com/shorts/rMW_sB5…

Poster in a Short 🎥 Millie Beament from UCL her work at #ADPD2026 on plasma p tau217 and its reliability for Alzheimer’s diagnosis. youtube.com/shorts/dko6qUw…